Genopathy
Gene-Disorder Association · Article
Gene
TSC2
TSC Complex Subunit 2
Manually curatedApproved treatment annotated
Association Review

In brief

The association between TSC2 (TSC Complex Subunit 2) and Renal Cell Carcinoma is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 1
Compounds 3
Trials 181of 1,658 via TSC2 compounds
Publications 15
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
TSC2

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Renal Cell Carcinoma

The disorder

8 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Interventions

Therapeutics

3 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
06
Human studies

Clinical trials

1,658 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
07
Literature

Reading

15 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
08
Provenance

References & sources

13 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access